CClinicalTrials.gg
TerminatedNCT02032732Updated Nov 29, 2018

Utilization of Leukocyte Esterase in the Diagnosis of Pediatric Joint Infections

An observational study in Joint Infection and Septic Arthritis, sponsored by University of Tennessee. Terminated at 1 site in United States. Open to participants aged 3 Months to 18 Years. Per ClinicalTrials.gov, last updated 2018-11-29.

Sponsored by University of Tennessee · Observational

Why this study was terminated
Principal Investigator resigned from institution
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
9
Ages
3 Months to 18 Years
Sex
All
01

Study summary

Pediatric joint infections are a common diagnostic dilemma encountered by treating orthopaedic surgeons. No single test is sensitive or specific enough to stand alone in determining the presence of joint infection.

The purpose of this study is to test the usefulness of a chemical test strip to detect infection in fluid that is removed from a joint (intra-articular aspiration) in pediatric patients. The test strip measures an enzyme called leukocyte esterase, which has been shown to be useful in detecting the presence of infection in fluids from other parts of the body. This study will assess the efficacy of the leukocyte esterase test as a diagnostic tool for evaluating pediatric joint infections. The hypothesis of the study is that a positive leukocyte esterase test identifies a septic joint in pediatric patients undergoing intraoperative joint aspiration.

Read the detailed description

Pediatric patients requiring an intra-articular joint aspiration for suspected infection or for other reasons will have a leukocyte esterase test performed on fluid removed from the joint. A convenience sample of consecutive patients will be screened according to inclusion/exclusion criteria and enrolled in the study by informed consent. All patients who will be screened for the study will have already been identified as needing an intra-articular joint aspiration in accordance with standard of care. All patients who are enrolled in the study will have the leukocyte esterase test performed on the fluid that is aspirated. Results of the test strip will be recorded.

02

Conditions studied

  • Joint Infection
  • Septic Arthritis
03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's enrollment of 9 is below the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

University of Tennessee is the lead sponsor of 139 studies on the registry; 21 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

pediatric patients at a tertiary referral center who will receive an intra-articular aspiration

Inclusion criteria

  • All patients at this facility over the age of 3 months and below the age of 18 years who receive an intra-articular aspiration

Exclusion criteria

Exclusion Criteria:

  • Immunocompromised patients
  • Renal failure patients
  • Patients younger than 3 months old
  • Patients 18 years of age or older
  • Volume of aspirate is less than 1.5 mL
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
9 participants (actual)
Patient registry
No

Groups and cohorts

  • suspected infection

    leukocyte esterase test on fluid removed by intra-articular aspiration for suspected infection

    Other: leukocyte esterase test

  • no suspected infection

    leukocyte esterase test on fluid removed by intra-articular aspiration for reason other than suspected infection

    Other: leukocyte esterase test

Interventions

  • Otherleukocyte esterase test

    leukocyte esterase test on fluid removed by intra-articular aspiration

06

What researchers measure

Primary outcomes

  1. leukocyte esterase level using a leukocyte esterase test strip

    A positive leukocyte esterase test strip will be considered an indicator of a septic joint

    Time frame: at the time of an intraoperative joint aspiration

Secondary outcomes

  1. baseline leukocyte esterase level for pediatric patients using a leukocyte esterase test strip

    Time frame: at the time of intraoperative joint aspiration

07

Study locations

1 site
  • Children's Orthopaedics, Erlanger Health System
    Chattanooga, Tennessee 37403, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02032732
Lead sponsor
University of Tennessee
Responsible party
Sponsor
First posted
Jan 10, 2014
Start date
Dec 2013
Primary completion
Dec 2015
Completion
Dec 2016
Last update
Nov 29, 2018

Study contacts

Julie Zielinski, M.D.
principal investigator · UTCOM Chattanooga/Erlanger Health System

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion